IPP Bureau
Poly Medicure posts consolidated Q2 FY24 PAT at Rs. 62.18 Cr
By IPP Bureau - November 06, 2023
Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023
Henkel launches new medical grade wearables device light cure adhesives
By IPP Bureau - November 04, 2023
The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 h
Zydus, Guardant Health to promote Guardant360 genomic tests for cancers in India and Nepal
By IPP Bureau - November 04, 2023
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Lupin receives tentative approval from USFDA for Selexipag for injection
By IPP Bureau - November 04, 2023
This product will be manufactured at Lupin's Nagpur facility in India
Tatva Chintan Pharma Chem reports Q2 FY24 consolidated PAT at Rs. 7.78 Cr
By IPP Bureau - November 04, 2023
Tatva Chintan Pharma Chem has reported total income of Rs. 97.42 crores during the period ended September 30, 2023
The Prostate Cancer Foundation and Bayer announce Bayer – PCF Darolutamide Challenge Awards
By IPP Bureau - November 03, 2023
In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
Can-Fite signs agreement with Collaborations Pharmaceuticals to develop anti-cancer drugs using AI
By IPP Bureau - November 03, 2023
This project will aim to develop a next-generation A3 adenosine receptor drug agonists
Lyka Labs posts Q2 FY24 loss at Rs. 48.65 lakhs
By IPP Bureau - November 03, 2023
Lyka Labs has reported total income of Rs. 28.23 crores during the period ended September 30, 2023
Morepen Laboratories posts Q2 FY24 consolidated PAT at Rs. 21.25 Cr
By IPP Bureau - November 03, 2023
Morepen Laboratories has reported total income of Rs. 425 crores during the quarter ended September 30, 2023
Dabur India posts Q2 FY24 consolidated PAT at Rs. 515.05 Cr
By IPP Bureau - November 03, 2023
The company has posted net profit of Rs.978.93 crores for the 6 months period ended September 30, 2023
Lincoln Pharmaceuticals posts Q2 FY24 consolidated PAT at Rs. 27.65 Cr
By IPP Bureau - November 03, 2023
Lincoln Pharmaceuticals has reported total income of Rs. 164.68 crores during the period ended September 30, 2023
Dr Lal Path Labs posts Q2 FY24 consolidated PAT at Rs. 109.3 Cr
By IPP Bureau - November 03, 2023
Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023
Jubilant Ingrevia posts Q2 FY24 consolidated PAT at Rs. 57.49 Cr
By IPP Bureau - November 02, 2023
The company has posted net profit of Rs.115.08 crores for half year ended September 30, 202
Zydus acquires UK based LiqMeds Group
By IPP Bureau - November 02, 2023
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Aster DM Healthcare launches a 506-bed multi-specialty hospital in Bengaluru
By IPP Bureau - November 02, 2023
Aster Whitefield will be Aster's 3 rd multi-specialty hospital in Bengaluru and overall 19th hospital in India
